Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Tokyo Joe's Cafe / Societe Anonyme/No Pennies -- Ignore unavailable to you. Want to Upgrade?

To: Tom Latham who wrote (57703)	2/23/1999 7:55:00 AM
From: QuietWon	Read Replies (2) \| Respond to of 119973

GENE - at symposium commencing today; rumor of multi-million (100 mill) deal going to happen. 1. presenting at conference in Europe - starts today - and we all know that volume comes in once people hear about things - and its typically institutional investors - very little downside imo 2. Action at close yesterday buys 3. Financial partner: Schering-Plough - not slouch there 4. GENE getting milestone payments for ASTHMA - Feb 2 5. GENE getting milestone payments for two medically important fungal pathogens - Jan 20 6. GENE and Astra - discover genes to help treat ulcers - Jan 13 biz.yahoo.com The point is revenues kicking in , stock has little downside, and good potential upside - gene analyses generates fee income as well - royalties